Highlights

CDSCO extends shelf life of ‘Covaxin’ to 12 months
The approval is based on the availability of additional stability data: Bharat Biotech
Bharat Biotech had sought extension of shelf life to 24 months in April

Latest news

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Emotion, tears as Messi retires from Argentina national team

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

Arun Govil returns to ‘Ramayana’ as King Dashrath in new poster

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

AAP stages ‘vote theft’ protest in Delhi, workers stopped by police barricades

Drug regulator extends shelf life of Covaxin to 12 months

Name: Drug regulator extends shelf life of Covaxin to 12 months
Uploaded: 2021-11-03T20:41:34.000+05:30
Duration: T00M50S
Channel: Editorji News Desk
Description: The Biotechnology company Bharat Biotech, on Tuesday said that the Central Drugs Standard Control(CDSCO) has approved the extension of the shelf-life of the most used vaccines in India, Covaxin up to 12 months, from the date of...

The extension came just hours before WHO gave Covaxin approval for emergency use.

Updated: Sep 02, 2022 10:53

Editorji News Desk

Join our WhatsApp Channel

Drug regulator extends shelf life of Covaxin to 12 months

Covaxin-maker Bharat Biotech on Tuesday said that the Central Drugs Standard Control has approved the extension of the vaccine's shelf-life to up to 12 months from the date of manufacture.

The company said that the approval is based on additional stability data, which was submitted to Central Drugs Standard Control.

Earlier this year, the Hyderabad-based Bharat Biotech had written to India’s drug regulatory body seeking an extension on the shelf life of Covaxin from a period of six months to 24 months.

The extension came just hours before WHO gave Covaxin approval for emergency use.

Bharat Biotech was permitted the sale and distribution of its indigenously developed Covid-19 vaccine ”Covaxin” with a shelf life of six months when kept at 2°C-8°C.

ALSO WATCH: WHO approves Bharat Biotech's Covaxin for emergency use